
|Articles|August 2, 2001
- Pharmaceutical Technology-08-02-2001
- Volume 25
- Issue 8
Changes and Challenges for CDER
Author(s)Jill Wechsler
The Center for Drug Evaluation and Research is adopting new approaches to how it oversees the development and approval of new drugs and how it ensures the safe use of prescription drugs by the public.
Advertisement
Articles in this issue
over 24 years ago
Report on the Industry Blend Uniformity Practices Surveyover 24 years ago
Interphex Presents a Wide Array of Packaging InnovationsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CNPV Deep Dive: Perspectives on Accelerated FDA Review From the C-Suite to the Manufacturing Floor
2
Is Pharma Solving the Right Problem with its Data Transformation Efforts?
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
4
How Codexis is Redefining Pharma Biocatalysis
5




